Clik here to view.
Medtronic’s new Ev3 unit pays $1.3m in whistleblower suit
The Ev3 subsidiary Medtronic (NYSE:MDT) acquired along with Covidien yesterday delivered good news and bad: FDA clearance for a new aneurysm treatment and a $1.25 million hit in a whistleblower...
View ArticleClik here to view.
MDT’s Ev3 pays $1.3m in whistleblower suit | The week in medtech M&A
Medtronic's new Ev3 unit pays $1.3m in whistleblower suit February 6, 2015 by Brad Perriello The Ev3 subsidiary Medtronic acquired along with Covidien yesterday delivered good news and bad: FDA...
View ArticleClik here to view.
MDT’s Ev3 pays $1.3m in whistleblower suit | Medtech legal news for the week...
Medtronic's new Ev3 unit pays $1.3m in whistleblower suit February 6, 2015 by Brad Perriello The Ev3 subsidiary Medtronic acquired along with Covidien yesterday delivered good news and bad: FDA...
View ArticleClik here to view.
PAD: Medtronic wins expanded FDA nod for Protégé GPS stent
Medtronic (NYSE:MDT) today said it won expanded approval from the FDA for the Protégé GPS peripheral stent it acquired along with Covidien earlier this year. The Protégé GPS self-expanding stent is...
View ArticleClik here to view.
BSX wins CE Mark, FDA nod for new S-ICD | Regulatory news for the week of...
Boston Scientific wins CE Mark, FDA nod for smaller 'leadless' ICD March 17, 2015 by Brad Perriello Boston Scientific today said it won both CE Mark approval in Europe and a nod at home from the FDA...
View ArticleClik here to view.
Coating issue still plagues the Pipeline device as Medtronic issues another...
The coating issue that’s bedeviled the Pipeline device made by Medtronic (NYSE:MDT) last week prompted another recall for the brain aneurysm treatment. Originally developed by Ev3, the Pipeline device...
View ArticleClik here to view.
RIP serial medtech entrepreneur Spencer | Personnel Moves November 10, 2016
Serial medtech entrepreneur Dale Spencer died last week in Scottsdale, Ariz, according to the Medical Alley Association. Spencer helped found more than a dozen medical device companies, including...
View ArticleClik here to view.
Medtronic’s Ev3 wins 2nd appeal in ex-rep’s whistleblower lawsuit
A federal appeals court last week dismissed a whistleblower lawsuit filed by a former sales rep for Medtronic (NYSE:MDT) subsidiary Ev3, ruling that the allegations weren’t strong enough to sustain a...
View ArticleClik here to view.
Covidien closes enrollment on ev3 atherectomy device study
Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year. The Mansfield, Mass.-based...
View ArticleClik here to view.
Covidien completes enrollment on ev3 atherectomy device study | Research roundup
Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year. The Mansfield, Mass.-based...
View ArticleClik here to view.
ev3 pays off big for Covidien
The flurry of moves Covidien plc (NYSE:COV) made in 2010 are starting to pay off for the Mansfield, Mass.-based medical products conglomerate. New business from its $2.6 billion ev3 acquisition helped...
View ArticleClik here to view.
Med-tech in the OC: A Q&A with OCTANe’s Matthew Jenusaitis
Matthew Jenusaitis knows a little something about regional hotbeds of innovation in the med-tech space. Having spent 15 years at Boston Scientific Corp. (NYSE:BSX) in numerous executive marketing and...
View ArticleClik here to view.
Covidien names new vascular leader | Personnel Moves
Covidien (NYSE:COV) named Stacy Enxing Seng president of its $1.4 billion global vascular therapies business. Enxing Seng, 47, will lead the division’s 4,000 employees, reporting to Peter Wehrly,...
View ArticleClik here to view.
Covidien touts FDA clearance for “game-changing” Solitaire revascularization...
Covidien plc (NYSE:COV) won FDA clearance for its Solitaire FR revascularization device for removing blood clots and restoring blood flow in the brains of patients suffering acute ischemic stroke. The...
View ArticleClik here to view.
FDA warns on Covidien’s liquid embolic system following 9 patient deaths
The FDA issued a safety alert after receiving reports of more than 100 adverse events, including 9 patient deaths, that may have been caused by Onyx brain blood vessel plugs made by Covidien...
View ArticleClik here to view.
Layoffs: Covidien to shutter South Carolina plant, cutting 595 jobs
Covidien (NYSE:COV) will close a manufacturing facility in Seneca, S.C., and move the operation to Costa Rica, resulting in nearly 600 layoffs. The Seneca facility manufactures vascular products for...
View ArticleClik here to view.
Mixed feelings for Covidien’s Pipeline embolization device following deaths
Researchers offered mixed messages on the safety and effectiveness of Covidien (NYSE:COV) subsidiary ev3 Inc.’s Pipeline embolization device, lauding the system as an option for patients with...
View ArticleClik here to view.
Aneurysm: Covidien touts pivotal study on Pipeline embolization device
Covidien (NYSE:COV) subsidiary ev3 Inc. is touting the results of a pivotal trial of its Pipeline aneurysm embolization device, showing that the technology "offers a reasonably safe and effective...
View ArticleClik here to view.
Jury hands Covidien’s ev3 subsidiary a possible $275M loss
Covidien (NYSE:COV) is on the hook for a $175 million milestone owed by subsidiary ev3 Inc. to a company it acquired 11 years ago, plus another possible $100 million in interest, after a Delaware...
View ArticleClik here to view.
Covidien’s got a ‘new approach’ to peripheral arterial disease
Massachusetts medical device giant Covidien (NYSE:COV) released results from a pair of studies, supporting use of the company’s EverFlex self-expanding stent and combining directional atherectomy with...
View Article